| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 418796-54-0 | Benzamide,N-[1-[[(4-methoxyphenyl)amino]carbonyl]-1,3-pentadien-1-yl]-; Benzamide,N-[1-[[(4-methoxyphenyl)amino]carbonyl]-1,3-pentadienyl]- (9CI) |  | C20H20N2O3 | 詳情 | 供應商 | |
| 418796-45-9 | Benzamide,N-[1-[[(3-methoxyphenyl)amino]carbonyl]-1,3-pentadien-1-yl]-; Benzamide,N-[1-[[(3-methoxyphenyl)amino]carbonyl]-1,3-pentadienyl]- (9CI) |  | C20H20N2O3 | 詳情 | 供應商 | |
| 74717-58-1 | L-Tryptophan,N-(1-oxo-3-phenylpropyl)-; N-b-Phenylpropionyl-L-tryptophan |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127654-04-0 | Hexanoic acid,6-(6-methoxy-11H-pyrido[4,3-c][2]benzazepin-11-ylidene)-, (E)- (9CI); 11H-Pyrido[4,3-c][2]benzazepine,hexanoic acid deriv. |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127654-05-1 | Hexanoic acid,6-(6-methoxy-11H-pyrido[4,3-c][2]benzazepin-11-ylidene)-, (Z)- (9CI); 11H-Pyrido[4,3-c][2]benzazepine,hexanoic acid deriv. |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127653-88-7 | Hexanoic acid,6-(5,6-dihydro-7-methyl-5-oxo-11H-pyrido[4,3-c][1]benzazepin-11-ylidene)-; 11H-Pyrido[4,3-c][1]benzazepine,hexanoic acid deriv. |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127654-15-3 | Hexanoic acid,6-(10,11-dihydro-10-methyl-11-oxo-5H-pyrido[3,4-c][1]benzazepin-5-ylidene)-,(E)- (9CI); 5H-Pyrido[3,4-c][1]benzazepine,hexanoic acid deriv. |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127654-02-8 | Hexanoic acid,6-(5,6-dihydro-6-methyl-5-oxo-11H-pyrido[4,3-c][1]benzazepin-11-ylidene)-, (E)-(9CI); 11H-Pyrido[4,3-c][1]benzazepine,hexanoic acid deriv. |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127654-16-4 | Hexanoic acid,6-(10,11-dihydro-10-methyl-11-oxo-5H-pyrido[3,4-c][1]benzazepin-5-ylidene)-,(Z)- (9CI); 5H-Pyrido[3,4-c][1]benzazepine,hexanoic acid deriv. |  | C20H20N2O3 | 詳情 | 供應商 | |
| 127654-03-9 | Hexanoic acid,6-(5,6-dihydro-6-methyl-5-oxo-11H-pyrido[4,3-c][1]benzazepin-11-ylidene)-,(6Z)-; Hexanoicacid, 6-(5,6-dihydro-6-methyl-5-oxo-11H-pyrido[4,3-c][1]benzazepin-11-ylidene)-,(Z)-; 11H-Pyrido[4,3-c][1]benzazepine, hexanoic acid deriv.; KF 13218 |  | C20H20N2O3 | 詳情 | 供應商 | |
| 172985-15-8 | Methanone,(1-amino-8,9-dihydro-5,8,8-trimethyl-6H-furo[2,3-b]pyrano[4,3-d]pyridin-2-yl)phenyl- |  | C20H20N2O3 | 詳情 | 供應商 | |
| 23564-90-1 | 1-Naphthalenecarboximidamide,N-(3,4,5-trimethoxyphenyl)-; 1-Naphthamidine,N-(3,4,5-trimethoxyphenyl)- (8CI) |  | C20H20N2O3 | 詳情 | 供應商 | |
| 113206-32-9 | 1,8-Naphthyridin-2(1H)-one,3-[4-(acetyloxy)butyl]-1-phenyl-; UP 5145-52 |  | C20H20N2O3 | 詳情 | 供應商 | |
| 133550-41-1 | 酪氨酸磷酸化抑制劑AG 556 | 2-Propenamide,2-cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenylbutyl)-, (2E)-; 2-Propenamide,2-cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenylbutyl)-, (E)-; AG 556; Tyrphostin AG556 |  | C20H20N2O3 | 詳情 | 供應商 |
| 149092-35-3 | 2-Propenamide,2-cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenylbutyl)-; TyrphostinB 56 |  | C20H20N2O3 | 詳情 | 供應商 | |
| 25912-33-8 | 2,4(1H,3H)-Pyrimidinedione,1-[[3-(3-phenylpropoxy)phenyl]methyl]-; Uracil,1-[m-(3-phenylpropoxy)benzyl]- (8CI); NSC 211582 |  | C20H20N2O3 | 詳情 | 供應商 | |
| 178408-26-9 | 2-Piperazinone,3-[2-(4-ethoxyphenyl)-2-oxoethylidene]-1-phenyl-; Piperazinone,3-[2-(4-ethoxyphenyl)-2-oxoethylidene]-1-phenyl- (9CI) |  | C20H20N2O3 | 詳情 | 供應商 | |
| 14222-11-8 | 2H-1-Benzopyran-2-one,7-hydroxy-8-(1-piperidinylmethyl)-4-(3-pyridinyl)-; Coumarin,7-hydroxy-8-(piperidinomethyl)-4-(3-pyridyl)- (8CI) |  | C20H20N2O3 | 詳情 | 供應商 | |
| 112392-95-7 | 3-Isoquinolinecarboxylicacid, 2-[2-(dimethylamino)ethyl]-1,2-dihydro-1-oxo-4-phenyl- |  | C20H20N2O3 | 詳情 | 供應商 | |
| 75483-10-2 | 3-Quinolinecarboxylicacid, 1,2-dihydro-1-methyl-4-[(4-methylphenyl)amino]-2-oxo-, ethyl ester; Ethyl 1-methyl-4-((4-methylphenyl)amino)-2-oxo-1,2-dihydro-3-quinoline carboxylate |  | C20H20N2O3 | 詳情 | 供應商 | |